At the Hairy Cell Leukemia Foundation 2025 Conference in Bologna, Italy, we had the opportunity to sit down with Dr. Dima El-Sharkawi for a live interview. The discussion focused on how hairy cell ...
Geron Corporation , a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that five abstracts ? one oral and four poster ...
Opinion
2hon MSNOpinion
Back pain during pregnancy is often dismissed as a passing discomfort—a nurse explains why it should be taken seriously
About half to three-quarters of expectant mothers experience pain during pregnancy that is largely untreated, contributing to preventable suffering and harm. Many mothers avoid medications and ...
ORLANDO, FLORIDA / ACCESS Newswire / October 30, 2025 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced its ...
Bells Predictive Analytics: Developed in collaboration with VNS Health, the Hospice Visits in the Last Days of Life (HVLDL) algorithm within Bells Predictive Analytics helps identify risk of mortality ...
INDICATION AUCATZYL ® is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute ...
The funding will be used to support reviews from two third-party consulting agencies, MSA Consultants and the Antara Group, ...
Seventeen people representing a wide range of interests comprise the search committee, which held its initial meeting Oct. 9 and will recommend about six candidates for consideration by UW’s Board ...
ORLANDO, FLORIDA / ACCESS Newswire / October 30, 2025 / RedChip Companies will host an investor webinar with NDT Pharmaceuticals Inc. (OTC PINK:NDTP), a company focused on advancing innovative ...
Michael Fassnacht is former CEO of World Business Chicago and is now chief growth officer at Clayco in Chicago. You'll find his previous "Beyond the Status Quo" columns here.
Joint Commission today announced the appointment of James I. Merlino, MD, as chief operating officer (COO), effective Jan. 1, 2026. Dr. Merlino currently serves as the organization’s chief innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback